Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05186753
Title (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cogent Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | NOR | NLD | ITA | IRL | GRC | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BEL | AUT | AUS


No variant requirements are available.